VYGR Voyager Therapeutics, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $107.7M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $138.7K |
| 2022-Q2 | $2.7M | $35.6K |
| 2022-Q3 | $0 | $6.0M |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $39.0M | $14.3M |
| 2023-Q2 | $0 | $125.1K |
| 2023-Q3 | $0 | $145.1K |
| 2023-Q4 | $0 | $94.8K |
| 2024-Q1 | $0 | $211.9K |
| 2024-Q2 | $0 | $132.9K |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $71.6K |
| 2025-Q1 | $0 | $250.5K |
| 2025-Q2 | $0 | $71.9K |
| 2025-Q3 | $0 | $70.9K |
| 2025-Q4 | $0 | $36.6K |
| 2026-Q1 | $0 | $253.4K |
| 2026-Q2 | $0 | $44.5K |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$41.7M3 buy days
Sold$22.0M82 sell days
Net insider flow+$19.7Mnet buying · 5 years
Latest trade2026-04-02Sandrock Alfred
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-04-02 | Sell | Sandrock Alfred | CEO | 11,511 | $3.87 | $44.5K | 1 |
| 2026-02-24 | Sell | Sandrock Alfred | CEO | 14,197 | $3.79 | $53.8K | 1 |
| 2026-02-24 | Sell | Swartz Robin | COO | 6,458 | $3.77 | $24.3K | 1 |
| 2026-02-24 | Sell | Jorgensen Nathan D. | CFO | 4,668 | $3.77 | $17.6K | 1 |
| 2026-02-24 | Sell | Carter Todd Alfred | Other C-suite | 4,174 | $3.76 | $15.7K | 1 |
| 2026-02-18 | Sell | Sandrock Alfred | CEO | 11,732 | $3.41 | $40.0K | 1 |
| 2026-02-18 | Sell | Swartz Robin | COO | 3,882 | $3.44 | $13.4K | 1 |
| 2026-02-18 | Sell | Carter Todd Alfred | Other C-suite | 3,301 | $3.44 | $11.4K | 1 |
| 2026-02-10 | Sell | Sandrock Alfred | CEO | 12,192 | $3.78 | $46.1K | 1 |
| 2026-02-10 | Sell | Swartz Robin | COO | 4,569 | $3.85 | $17.6K | 1 |
| 2026-02-10 | Sell | Carter Todd Alfred | Other C-suite | 3,525 | $3.85 | $13.6K | 1 |
| 2025-10-03 | Sell | Jorgensen Nathan D. | CFO | 7,666 | $4.78 | $36.6K | 1 |
| 2025-08-18 | Sell | Ferguson Toby | Other C-suite | 19,000 | $3.73 | $70.9K | 1 |
| 2025-04-02 | Sell | Sandrock Alfred | CEO | 10,885 | $3.43 | $37.3K | 1 |
| 2025-04-02 | Sell | Ferguson Toby | Other C-suite | 10,086 | $3.43 | $34.6K | 1 |
| 2025-02-20 | Sell | Sandrock Alfred | CEO | 11,702 | $4.24 | $49.6K | 1 |
| 2025-02-20 | Sell | Swartz Robin | COO | 3,894 | $4.25 | $16.5K | 1 |
| 2025-02-20 | Sell | Carter Todd Alfred | Other C-suite | 3,305 | $4.26 | $14.1K | 1 |
| 2025-02-11 | Sell | Sandrock Alfred | CEO | 16,644 | $4.45 | $74.1K | 1 |
| 2025-02-11 | Sell | Swartz Robin | COO | 6,950 | $4.45 | $30.9K | 1 |
| 2025-02-11 | Sell | Carter Todd Alfred | Other C-suite | 5,413 | $4.45 | $24.1K | 1 |
| 2025-02-11 | Sell | Fahey Sandell Jacquelyn | Other C-suite | 4,358 | $4.45 | $19.4K | 1 |
| 2025-01-14 | Sell | Swartz Robin | COO | 3,087 | $5.09 | $15.7K | 1 |
| 2025-01-14 | Sell | Carter Todd Alfred | Other C-suite | 1,191 | $5.13 | $6.1K | 1 |
| 2024-12-23 | Sell | Swartz Robin | COO | 6,500 | $5.65 | $36.7K | 1 |
| 2024-10-02 | Sell | Fahey Sandell Jacquelyn | Other C-suite | 5,999 | $5.82 | $34.9K | 1 |
| 2024-04-02 | Sell | Sandrock Alfred | CEO | 12,115 | $9.86 | $119.5K | 1 |
| 2024-04-02 | Sell | Swartz Robin | COO | 1,357 | $9.88 | $13.4K | 1 |
| 2024-02-21 | Sell | Sandrock Alfred | CEO | 13,033 | $7.46 | $97.2K | 1 |
| 2024-02-21 | Sell | Swartz Robin | COO | 3,966 | $7.45 | $29.5K | 1 |
| 2024-02-21 | Sell | PFREUNDSCHUH PETER P. | CFO | 3,764 | $7.46 | $28.1K | 1 |
| 2024-02-21 | Sell | Carter Todd Alfred | Other C-suite | 3,365 | $7.47 | $25.1K | 1 |
| 2024-02-20 | Sell | Carter Todd Alfred | Other C-suite | 602 | $7.68 | $4.6K | 1 |
| 2024-01-17 | Sell | Swartz Robin | COO | 2,543 | $7.15 | $18.2K | 1 |
| 2024-01-17 | Sell | Carter Todd Alfred | Other C-suite | 1,266 | $7.18 | $9.1K | 1 |
| 2023-10-03 | Sell | PFREUNDSCHUH PETER P. | CFO | 13,567 | $6.99 | $94.8K | 1 |
| 2023-09-15 | Sell | Carter Todd Alfred | Other C-suite | 10,500 | $8.16 | $85.7K | 1 |
| 2023-07-06 | Sell | Carter Todd Alfred | Other C-suite | 5,500 | $10.80 | $59.4K | 1 |
| 2023-06-30 | Sell | Carter Todd Alfred | Other C-suite | 5,000 | $11.41 | $57.0K | 1 |
| 2023-04-03 | Sell | Sandrock Alfred | CEO | 7,437 | $7.83 | $58.2K | 1 |
| 2023-04-03 | Sell | Swartz Robin | COO | 1,259 | $7.83 | $9.9K | 1 |
| 2023-03-20 | Sell | Hesslein Robert W. | General counsel | 4,410 | $7.76 | $34.2K | 1 |
| 2023-03-20 | Sell | Swartz Robin | COO | 3,654 | $7.76 | $28.4K | 1 |
| 2023-03-20 | Sell | Carter Todd Alfred | Other C-suite | 2,193 | $7.76 | $17.0K | 1 |
| 2023-03-15 | Sell | Swartz Robin | COO | 15,373 | $8.20 | $126.1K | 1 |
| 2023-02-23 | Buy | NEUROCRINE BIOSCIENCES INC | 10% owner | 4,395,588 | $8.88 | $39.0M | 1 |
| 2023-02-17 | Sell | Hesslein Robert W. | General counsel | 3,297 | $7.45 | $24.6K | 1 |
| 2023-02-17 | Sell | Carter Todd Alfred | Other C-suite | 738 | $7.45 | $5.5K | 1 |
| 2023-02-13 | Sell | Hesslein Robert W. | General counsel | 2,868 | $7.67 | $22.0K | 1 |
| 2023-02-13 | Sell | Carter Todd Alfred | Other C-suite | 797 | $7.67 | $6.1K | 1 |
| 2023-02-01 | Sell | TEPPER ROBERT I | 10% owner | 128,642 | $9.32 | $1.2M | 1 |
| 2023-01-31 | Sell | TEPPER ROBERT I | 10% owner | 185,000 | $9.25 | $1.7M | 1 |
| 2023-01-30 | Sell | TEPPER ROBERT I | 10% owner | 75,000 | $9.03 | $677.2K | 1 |
| 2023-01-27 | Sell | TEPPER ROBERT I | 10% owner | 50,000 | $9.02 | $451.0K | 1 |
| 2023-01-25 | Sell | TEPPER ROBERT I | 10% owner | 50,000 | $9.22 | $461.0K | 1 |
| 2023-01-24 | Sell | TEPPER ROBERT I | 10% owner | 100,000 | $9.27 | $927.0K | 1 |
| 2023-01-23 | Sell | TEPPER ROBERT I | 10% owner | 55,000 | $9.06 | $498.3K | 1 |
| 2023-01-20 | Sell | TEPPER ROBERT I | 10% owner | 100,000 | $9.15 | $915.0K | 1 |
| 2023-01-17 | Sell | Swartz Robin | COO | 2,188 | $9.85 | $21.5K | 2 |
| 2023-01-17 | Sell | Hesslein Robert W. | General counsel | 2,188 | $9.85 | $21.5K | 2 |
| 2023-01-17 | Sell | Carter Todd Alfred | Other C-suite | 1,106 | $9.85 | $10.9K | 2 |
| 2023-01-11 | Sell | EcoR1 Capital, LLC | 10% owner | 110,000 | $8.50 | $935.0K | 1 |
| 2023-01-10 | Sell | EcoR1 Capital, LLC | 10% owner | 336,400 | $8.05 | $2.7M | 1 |
| 2023-01-09 | Sell | EcoR1 Capital, LLC | 10% owner | 456,000 | $7.67 | $3.5M | 1 |
| 2023-01-06 | Sell | Carter Todd Alfred | Other C-suite | 388 | $6.41 | $2.5K | 1 |
| 2022-08-25 | Sell | TEPPER ROBERT I | 10% owner | 200,000 | $6.22 | $1.2M | 1 |
| 2022-08-24 | Sell | TEPPER ROBERT I | 10% owner | 149,972 | $6.09 | $913.3K | 1 |
| 2022-08-16 | Sell | TEPPER ROBERT I | 10% owner | 128,456 | $6.04 | $775.9K | 1 |
| 2022-08-15 | Sell | TEPPER ROBERT I | 10% owner | 135,808 | $6.04 | $820.3K | 1 |
| 2022-08-12 | Sell | TEPPER ROBERT I | 10% owner | 348,007 | $6.12 | $2.1M | 1 |
| 2022-07-14 | Sell | Higgins Michael J | Director | 13,891 | $6.70 | $93.1K | 1 |
| 2022-07-14 | Sell | PIERCE GLENN | Director | 9,512 | $6.70 | $63.7K | 1 |
| 2022-06-23 | Buy | EcoR1 Capital, LLC | 10% owner | 376,000 | $5.66 | $2.1M | 1 |
| 2022-06-21 | Buy | EcoR1 Capital, LLC | 10% owner | 101,400 | $5.28 | $535.4K | 1 |
| 2022-04-04 | Sell | Hesslein Robert W. | General counsel | 2,786 | $8.25 | $23.0K | 1 |
| 2022-04-04 | Sell | Swartz Robin | COO | 1,527 | $8.25 | $12.6K | 1 |
| 2022-03-21 | Sell | Hesslein Robert W. | General counsel | 4,955 | $8.29 | $41.1K | 2 |
| 2022-03-21 | Sell | Swartz Robin | COO | 4,413 | $8.29 | $36.6K | 2 |
| 2022-03-21 | Sell | Burek Julie | VP | 2,649 | $8.29 | $22.0K | 2 |
| 2022-02-17 | Sell | Hesslein Robert W. | General counsel | 4,100 | $3.55 | $14.6K | 1 |
| 2022-02-17 | Sell | Burek Julie | VP | 789 | $3.55 | $2.8K | 1 |
| 2022-02-11 | Sell | Hesslein Robert W. | General counsel | 3,252 | $3.36 | $10.9K | 1 |
| 2022-02-11 | Sell | Burek Julie | VP | 361 | $3.36 | $1.2K | 1 |
| 2022-01-12 | Sell | Burek Julie | VP | 265 | $3.06 | $811 | 1 |
| 2022-01-03 | Sell | Burek Julie | VP | 3,063 | $2.83 | $8.7K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 10% owner | $39.0M | $0 | 2023-02-23 |
| TEPPER ROBERT I | 10% owner | $0 | $12.7M | 2023-02-01 |
| EcoR1 Capital, LLC | 10% owner | $2.7M | $7.1M | 2023-01-11 |
| Sandrock Alfred | CEO | $0 | $620.4K | 2026-04-02 |
| Swartz Robin | COO | $0 | $451.4K | 2026-02-24 |
| Carter Todd Alfred | Other C-suite | $0 | $367.9K | 2026-02-24 |
| Hesslein Robert W. | General counsel | $0 | $191.9K | 2023-03-20 |
| PFREUNDSCHUH PETER P. | CFO | $0 | $122.9K | 2024-02-21 |
| Ferguson Toby | Other C-suite | $0 | $105.5K | 2025-08-18 |
| Higgins Michael J | Director | $0 | $93.1K | 2022-07-14 |
| PIERCE GLENN | Director | $0 | $63.7K | 2022-07-14 |
| Fahey Sandell Jacquelyn | Other C-suite | $0 | $54.3K | 2025-02-11 |
| Jorgensen Nathan D. | CFO | $0 | $54.2K | 2026-02-24 |
| Burek Julie | VP | $0 | $35.5K | 2022-03-21 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.